Superworth

AtriCure price to sales ratio ATRC

Market value divided by revenue over the last twelve months, since 2012.

Today, Oct 23, 2026
5.3×
10-year median
5.2×
Against its 10-year history
51st
percentile: 0 is its lowest day, 100 its highest
10-year range
2.4× to 18.1×
Peer median
3.5×

AtriCure's price to sales ratio is 5.3× as of Oct 23, 2026.

That is above its ten-year median of 5.2×, close to the middle of its last ten years.

Over that time it ranged from 2.4× in Aug 2024 to 18.1× in Jul 2021.

The median for 10 medical instruments and supplies stocks of a similar size is 3.5×.

Price to sales ratio over time

The dashed line is the 10-year median and the shaded band the middle half of its days.

Open the interactive chart, with overlays and comparisons

Year by year

YearEnd of yearLowHigh
2026 so far5.3×2.4×5.3×
20253.9×3.0×4.5×
20243.3×2.4×4.4×
20234.4×4.2×7.4×
20226.5×5.1×11.6×
202112.3×11.6×18.1×
202011.9×4.4×12.3×
20195.7×4.4×6.6×
20185.9×3.1×6.7×
20173.7×3.4×5.2×
20164.3×3.1×5.1×
20155.9×4.4×6.7×
20145.3×4.3×6.8×
20135.1×1.8×5.1×
20121.6×1.5×2.4×

Against its peers

Companies in Medical - Instruments & Supplies nearest AtriCure's size, closest first, today.

CompanyPrice to sales ratio
ATRCAtriCure5.3×
WRBYWarby Parker3.5×
NVSTEnvista1.3×
UFPTUFP Technologies3.6×
ICUIICU Medical1.9×
INSPInspire Medical Systems2.3×
BMIBadger Meter5.0×
VNTVontier1.5×
LMATLemaitre Vascular7.4×
HAEHaemonetics4.0×
MMSIMerit Medical Systems3.5×
Peer median3.5×

Where AtriCure ranks

What the price to sales ratio tells you

Market value divided by revenue over the last twelve months. Useful for companies with little or no profit yet, since sales are harder to make negative than earnings.

Ignores margins entirely. A software company at 10× sales with 30% margins can be cheaper than a grocer at 1× sales with 2% margins.

More on AtriCure

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.